Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening

NCT01578850 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
491
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer